PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1364034-1	1992	Peptide YY (PYY), a new peptide found primarily in mucosal endocrine cells of the terminal ileum and colon, inhibits pentagastrin-stimulated gastric acid secretion in several species, including man.	Pentagastrin	117-129	peptide YY	Homo sapiens	0-10	
9200286-3	1997	METHODS: The effect of intravenous infusion of GLP-1 and PYY, either alone or in combination, on pentagastrin-induced acid secretion in eight healthy volunteers was examined.	Pentagastrin	97-109	peptide YY	Homo sapiens	57-60	
1364034-1	1992	Peptide YY (PYY), a new peptide found primarily in mucosal endocrine cells of the terminal ileum and colon, inhibits pentagastrin-stimulated gastric acid secretion in several species, including man.	Pentagastrin	117-129	peptide YY	Homo sapiens	12-15	
3557015-10	1987	Our present findings (in combination with our previous findings of inhibition of pentagastrin- and bethanechol-stimulated gastric acid secretion by PYY, independent of the vagal cholinergic mechanism) indicate that the action of PYY is either direct on the parietal cells or is mediated by yet another, unidentified, inhibitor.	Pentagastrin	81-93	peptide YY	Homo sapiens	148-151	
2083801-1	1990	In 6 healthy volunteers we investigated the effect of secretin and peptide YY (PYY) on gastric acid secretion stimulated by pentagastrin (100 ng/kg/h).	Pentagastrin	124-136	peptide YY	Homo sapiens	79-82	
2083801-6	1990	It is suggested that the interaction of PYY and secretin on pentagastrin-stimulated gastric acid secretion in normal man is of the additive type.	Pentagastrin	60-72	peptide YY	Homo sapiens	40-43	
3557015-10	1987	Our present findings (in combination with our previous findings of inhibition of pentagastrin- and bethanechol-stimulated gastric acid secretion by PYY, independent of the vagal cholinergic mechanism) indicate that the action of PYY is either direct on the parietal cells or is mediated by yet another, unidentified, inhibitor.	Pentagastrin	81-93	peptide YY	Homo sapiens	229-232	
3839479-4	1985	The middle dose of PYY (0.20 pmol X kg-1 X min-1) that increased plasma PYY levels by 27 +/- 2 pM caused a 90% +/- 18% (mean +/- SEM; p less than 0.001) reduction in the incremental gastric volume response to pentagastrin.	Pentagastrin	209-221	peptide YY	Homo sapiens	19-22	
3839479-4	1985	The middle dose of PYY (0.20 pmol X kg-1 X min-1) that increased plasma PYY levels by 27 +/- 2 pM caused a 90% +/- 18% (mean +/- SEM; p less than 0.001) reduction in the incremental gastric volume response to pentagastrin.	Pentagastrin	209-221	peptide YY	Homo sapiens	72-75	
3839479-5	1985	Similarly this dose of PYY caused a substantial inhibition of the acid (77% +/- 14%; p less than 0.005) and pepsin (96% +/- 22%; p less than 0.01) response to pentagastrin; in 2 subjects, pepsin output fell to below basal levels.	Pentagastrin	159-171	peptide YY	Homo sapiens	23-26